Cancer-on-chip: a breakthrough organ-on-a-chip technology in cancer cell modeling

Area of Science:

• Biomedical Engineering
• Oncology
• Drug Discovery

Background:

• Cancer is a leading global cause of death with complex molecular mechanisms.
• Developing effective cancer treatments is hindered by tumor microenvironment complexity.
• Organ-on-a-chip (OoC) technology presents a promising solution for pharmaceutical research and development costs.

Purpose of the Study:

• To summarize recent advancements in cancer cell treatment using OoC technology.
• To detail the OoC system and its application in simulating a 3D tumor microenvironment.
• To explore the potential of OoC in optimizing tumor modeling and cancer treatment strategies.

Main Methods:

• Review of the latest research on cancer cell treatment simulated in 3D microenvironments using OoC systems.
• Detailed discussion of the principles and components of OoC technology.
• Analysis of studies demonstrating OoC's capability in modeling tumor-specific conditions.

Main Results:

• OoC systems have shown significant progress in spatial modeling of cancer therapeutics.
• These systems improve physiological exposition criteria for drug testing.
• OoC technology facilitates a better understanding of tumor behavior in a controlled 3D environment.

Conclusions:

• OoC systems represent a breakthrough technology for cancer research and drug development.
• This technology offers a more physiologically relevant platform for studying cancer cell treatment.
• OoC systems hold significant promise for advancing cancer therapy, despite current limitations.